21.482 articles found

Covid-19: pharmacotherapeutic insights on various curative approaches in terms of vulnerability, comorbidities, and vaccination.

Kaur R, Singh S, Singh TG, Sood P, Robert J.

Inflammopharmacology · 2022-01-03

DOI: 10.1007/s10787-021-00904-wPMID: 34981320

Predictive Value of Ambulatory Objective Movement Measurement for Outcomes of Levodopa/Carbidopa Intestinal Gel Infusion.

Kilinçalp G, Sjöström AC, Eriksson B, Holmberg B, Constantinescu R, Bergquist F.

J Pers Med · 2022-01-02

DOI: 10.3390/jpm12010027PMID: 35055343

Mitochondrial dysfunction as a therapeutic target in Parkinson's Disease

Payne T.

· 2022-01-01

GuiltyTargets: Prioritization of Novel Therapeutic Targets With Network Representation Learning.

Muslu O, Hoyt CT, Lacerda M, Hofmann-Apitius M, Frohlich H.

IEEE/ACM Trans Comput Biol Bioinform · 2022-01-01

DOI: 10.1109/tcbb.2020.3003830PMID: 32750869

Flavonoids, the Family of Plant-Derived Antioxidants Making Inroads into Novel Therapeutic Design Against Ionizing Radiation-Induced Oxidative Stress in Parkinson's Disease.

Behl T, Kaur G, Sehgal A, Zengin G, Singh S, Ahmadi A, Bungau S.

Curr Neuropharmacol · 2022-01-01

DOI: 10.2174/1570159x19666210524152817PMID: 34030619

A Review on Chitosan in Drug Delivery for Treatment of Neurological and Psychiatric Disorders.

Shayganfard M.

Curr Pharm Biotechnol · 2022-01-01

DOI: 10.2174/1389201022666210622111028PMID: 34161209

Novel Drug Delivery System for Curcumin: Implementation to Improve Therapeutic Efficacy against Neurological Disorders.

Mohi-Ud-Din R, Mir RH, Wani TU, Shah AJ, Mohi-Ud-Din I, Dar MA, Pottoo FH.

Comb Chem High Throughput Screen · 2022-01-01

DOI: 10.2174/1386207324666210705114058PMID: 34225614

Insights into the Mechanism of the Therapeutic Potential of Herbal Monoamine Oxidase Inhibitors in Neurological Diseases.

Mannan A, Singh TG, Singh V, Garg N, Kaur A, Singh M.

Curr Drug Targets · 2022-01-01

DOI: 10.2174/1389450122666210707120256PMID: 34238153

Are Lysosomes Potential Therapeutic Targets for Parkinson's Disease?

Petese A, Cesaroni V, Cerri S, Blandini F.

CNS Neurol Disord Drug Targets · 2022-01-01

DOI: 10.2174/1871527320666210809123630PMID: 34370650

Pharmacotherapeutic Potential of Garlic in Age-Related Neurological Disorders.

Ahangar-Sirous R, Poudineh M, Ansari A, Nili A, Dana SMMA, Nasiri Z, Hosseini Z, Karami D, Mokhtari M, Deravi N.

CNS Neurol Disord Drug Targets · 2022-01-01

DOI: 10.2174/1871527320666210927101257PMID: 34579639

BAPST. A Combo of Common Use Drugs as Metabolic Therapy for Cancer: A Theoretical Proposal.

Romo-Perez A, Dominguez-Gomez G, Chavez-Blanco A, Taja-Chayeb L, Gonzalez-Fierro A, Garcia-Martinez E, Correa-Basurto J, Duenas-Gonzalez A.

Curr Mol Pharmacol · 2022-01-01

DOI: 10.2174/1874467214666211006123728PMID: 34620071

The Role of Pathogens and Anti-Infective Agents in Parkinson's Disease, from Etiology to Therapeutic Implications.

Shen S, Zhang C, Xu YM, Shi CH.

J Parkinsons Dis · 2022-01-01

DOI: 10.3233/jpd-212929PMID: 34719435